Wall St Engine
@wallstengine
Fast, accurate, consistent stock market news, earnings highlights & more. By Brillinsight. Not financial advice.
加入 March 2022
981 正在關注 205K 粉絲
Vaxcyte $PCVX says VAX-31, its 31-valent pneumococcal vaccine, met all primary endpoints in pivotal adult Phase 3.
It achieved noninferiority across all 32 serotype comparisons, with safety similar to PCV20/PCV21.
OPUS-2/3 data due H1 2027.
顯示更多
